Kiran Mazumdar-Shaw is nothing if not innovative.
Starting with a postgraduate degree in brewing from an Australian university, she built the largest biopharmaceutical company in India.
And, along the way, she dispensed with antagonistic unionists by automating her production line; developed and patented a solid substrate bioreactor that facilitated the cultivation and extraction of microorganisms used in the production of industrial enzymes; skirted around international patents with a revolutionary method for manufacturing human insulin in yeast; created new therapies for both psoriasis and cancer of the head and neck; and established a micro-insurance program that has the potential to provide quality health care and medicines to millions of Indian villagers for an annual fee of just $3 per head.
"The difference lies in our DNA"
Researchers @warwickuni use new approach to measure the influence of one brain region on another, referred to as ef… https://t.co/hew3eWdCLn— Kiran Mazumdar Shaw (@kiranshaw) December 14, 2017
Good effort by students of Srishti Institute of Art, Design and Technology in #Bengaluru who are working to tackle… https://t.co/8AtZHweAmg— Kiran Mazumdar Shaw (@kiranshaw) December 14, 2017